2023 Q3 Form 10-Q Financial Statement

#000076889923000104 Filed on July 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $473.2M $475.6M
YoY Change -17.81% -16.45%
Cost Of Revenue $349.0M $345.1M
YoY Change -16.86% -15.98%
Gross Profit $124.2M $130.5M
YoY Change -20.36% -17.69%
Gross Profit Margin 26.24% 27.44%
Selling, General & Admin $120.7M $119.7M
YoY Change -2.92% -1.89%
% of Gross Profit 97.22% 91.75%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.184M $6.280M
YoY Change -17.36% -13.32%
% of Gross Profit 4.98% 4.81%
Operating Expenses $120.7M $126.0M
YoY Change -2.92% 3.25%
Operating Profit -$2.726M $4.487M
YoY Change -111.32% -84.66%
Interest Expense -$103.0K -$980.0K
YoY Change -104.64% -128.5%
% of Operating Profit -21.84%
Other Income/Expense, Net $390.0K $578.0K
YoY Change -44.52% -625.45%
Pretax Income -$2.336M -$5.978M
YoY Change -109.42% -120.51%
Income Tax -$2.326M $1.345M
% Of Pretax Income
Net Earnings -$10.00K -$7.323M
YoY Change -100.05% -130.5%
Net Earnings / Revenue 0.0% -1.54%
Basic Earnings Per Share $0.00 -$0.24
Diluted Earnings Per Share $0.00 -$0.24
COMMON SHARES
Basic Shares Outstanding 31.00M shares 31.02M shares
Diluted Shares Outstanding 30.93M shares 30.97M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $47.11M $49.65M
YoY Change 7.62% 53.1%
Cash & Equivalents $47.11M $49.65M
Short-Term Investments
Other Short-Term Assets $5.755M $22.83M
YoY Change -16.97% 237.35%
Inventory
Prepaid Expenses
Receivables $276.2M $267.9M
Other Receivables $13.24M $13.41M
Total Short-Term Assets $359.6M $353.8M
YoY Change -12.0% -12.92%
LONG-TERM ASSETS
Property, Plant & Equipment $102.8M $153.2M
YoY Change 11.36% 70.09%
Goodwill $84.75M $85.05M
YoY Change -9.3% -9.52%
Intangibles $11.82M $13.16M
YoY Change -31.66% -30.72%
Long-Term Investments
YoY Change
Other Assets $13.84M $248.9M
YoY Change -26.02% 1364.55%
Total Long-Term Assets $555.4M $571.0M
YoY Change -3.26% -2.34%
TOTAL ASSETS
Total Short-Term Assets $359.6M $353.8M
Total Long-Term Assets $555.4M $571.0M
Total Assets $915.0M $924.9M
YoY Change -6.89% -6.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.88M $48.56M
YoY Change -9.21% -26.87%
Accrued Expenses $143.6M $140.1M
YoY Change 40.94% 43.24%
Deferred Revenue $3.825M
YoY Change -45.68%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $200.6M $199.2M
YoY Change -10.08% -14.44%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $1.496M $271.6M
YoY Change -7.65% 9324.32%
Total Long-Term Liabilities $1.496M $271.6M
YoY Change -7.65% 9324.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $200.6M $199.2M
Total Long-Term Liabilities $1.496M $271.6M
Total Liabilities $458.4M $470.8M
YoY Change -7.57% -10.33%
SHAREHOLDERS EQUITY
Retained Earnings $477.7M $473.8M
YoY Change -5.82% -1.96%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $456.6M $454.0M
YoY Change
Total Liabilities & Shareholders Equity $915.0M $924.9M
YoY Change -6.89% -6.68%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$10.00K -$7.323M
YoY Change -100.05% -130.5%
Depreciation, Depletion And Amortization $6.184M $6.280M
YoY Change -17.36% -13.32%
Cash From Operating Activities -$1.295M $11.71M
YoY Change -104.8% -56.07%
INVESTING ACTIVITIES
Capital Expenditures $7.357M $7.657M
YoY Change -184.63% -193.23%
Acquisitions
YoY Change
Other Investing Activities -$6.772M $3.606M
YoY Change -215.35% -47.3%
Cash From Investing Activities -$14.13M -$4.051M
YoY Change 400.67% 195.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.033M -9.471M
YoY Change 3725.93% -66.92%
NET CHANGE
Cash From Operating Activities -1.295M 11.71M
Cash From Investing Activities -14.13M -4.051M
Cash From Financing Activities -1.033M -9.471M
Net Change In Cash -16.46M -1.809M
YoY Change -168.22% -45.9%
FREE CASH FLOW
Cash From Operating Activities -$1.295M $11.71M
Capital Expenditures $7.357M $7.657M
Free Cash Flow -$8.652M $4.056M
YoY Change -124.26% -88.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
tbi Weighted Average Period Claim Payments And Receivables Above Deductible Limit
WeightedAveragePeriodClaimPaymentsAndReceivablesAboveDeductibleLimit
P17Y
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
tbi Payments To Acquire Restricted Investments Held To Maturity
PaymentsToAcquireRestrictedInvestmentsHeldToMaturity
9955000 usd
tbi Payments To Acquire Restricted Investments Held To Maturity
PaymentsToAcquireRestrictedInvestmentsHeldToMaturity
4950000 usd
tbi Proceeds From Maturity Of Restricted Investments Heldtomaturity
ProceedsFromMaturityOfRestrictedInvestmentsHeldtomaturity
15613000 usd
tbi Proceeds From Maturity Of Restricted Investments Heldtomaturity
ProceedsFromMaturityOfRestrictedInvestmentsHeldtomaturity
17826000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12427000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1116000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
34200000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
60939000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
509000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
536000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2514000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4132000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-91000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-147000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-36296000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-64682000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-20000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-494000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27879000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13190000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
135631000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103185000 usd
us-gaap Interest Paid Net
InterestPaidNet
453000 usd
us-gaap Interest Paid Net
InterestPaidNet
452000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3760000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8413000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
7793000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
7925000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3345000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3385000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8124000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4852000 usd
CY2023Q2 us-gaap Assets Held By Insurance Regulators
AssetsHeldByInsuranceRegulators
30064000 usd
CY2022Q4 us-gaap Assets Held By Insurance Regulators
AssetsHeldByInsuranceRegulators
29567000 usd
CY2023Q2 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
27153000 usd
CY2022Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
30857000 usd
CY2023Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
117206000 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
123678000 usd
CY2023Q2 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
30801000 usd
CY2022Q4 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
26479000 usd
CY2023Q2 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
882000 usd
CY2022Q4 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
3153000 usd
CY2023Q2 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
206106000 usd
CY2022Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
213734000 usd
CY2023Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
117206000 usd
CY2023Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
1000 usd
CY2023Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
3808000 usd
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
113399000 usd
CY2022Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
123678000 usd
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
6000 usd
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
4159000 usd
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
119525000 usd
CY2023Q2 tbi Discountedworkerscompensationreserveforexcessclaims
Discountedworkerscompensationreserveforexcessclaims
72000000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1558000 usd
CY2022Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3549000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1975000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-5560000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3212000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6687000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2408000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2572000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2130000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
5258000 usd
us-gaap Financing Receivable Allowance For Credit Loss Foreign Currency Translation
FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
-3000 usd
us-gaap Financing Receivable Allowance For Credit Loss Foreign Currency Translation
FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
14000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3493000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3987000 usd
CY2023Q2 tbi Prepaid Software Agreements Current
PrepaidSoftwareAgreementsCurrent
8869000 usd
CY2022Q4 tbi Prepaid Software Agreements Current
PrepaidSoftwareAgreementsCurrent
9994000 usd
CY2023Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
6411000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
9455000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
7545000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
13081000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22825000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32530000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3825000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3812000 usd
CY2023Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
6597000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
7077000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10422000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10889000 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
329352000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
235568000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
93784000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
8885000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
150000 usd
CY2023Q2 us-gaap Goodwill Gross
GoodwillGross
329502000 usd
CY2023Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
244453000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
85049000 usd
tbi Weighted Average Period Claim Payments Below Deductible Limit
WeightedAveragePeriodClaimPaymentsBelowDeductibleLimit
P6Y
CY2023Q2 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
250269000 usd
CY2022Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
270468000 usd
CY2023Q2 tbi Workers Compensation Discount Reserve Amount
WorkersCompensationDiscountReserveAmount
19158000 usd
CY2022Q4 tbi Workers Compensation Discount Reserve Amount
WorkersCompensationDiscountReserveAmount
19458000 usd
CY2023Q2 tbi Workers Compensation Liability Netof Discount
WorkersCompensationLiabilityNetofDiscount
231111000 usd
CY2022Q4 tbi Workers Compensation Liability Netof Discount
WorkersCompensationLiabilityNetofDiscount
251010000 usd
CY2023Q2 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
44840000 usd
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
50005000 usd
CY2023Q2 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
186271000 usd
CY2022Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
201005000 usd
us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
22400000 usd
us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
21500000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
465953000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
454045000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
465953000 usd
CY2022Q4 tbi Discountedworkerscompensationreserveforexcessclaims
Discountedworkerscompensationreserveforexcessclaims
76700000 usd
CY2023Q2 tbi Workers Compensation Claim Receivables
WorkersCompensationClaimReceivables
70700000 usd
CY2022Q4 tbi Workers Compensation Claim Receivables
WorkersCompensationClaimReceivables
75200000 usd
CY2023Q2 tbi Workers Compensation Expense
WorkersCompensationExpense
5900000 usd
CY2022Q2 tbi Workers Compensation Expense
WorkersCompensationExpense
9800000 usd
tbi Workers Compensation Expense
WorkersCompensationExpense
10700000 usd
tbi Workers Compensation Expense
WorkersCompensationExpense
21100000 usd
CY2023Q2 tbi Debt Instrument Leverage Ratio Threshold
DebtInstrumentLeverageRatioThreshold
3.00
CY2023Q2 tbi Debt Instrument Leverage Ratio
DebtInstrumentLeverageRatio
0.10
CY2023Q2 tbi Debt Instrument Fixed Charge Coverage Ratio Threshold
DebtInstrumentFixedChargeCoverageRatioThreshold
1.25
CY2023Q2 tbi Debt Instrument Fixed Charge Coverage Ratio
DebtInstrumentFixedChargeCoverageRatio
48.44
CY2023Q2 tbi Collateral Commitments Cash Collateral Held By Insurance Carriers
CollateralCommitmentsCashCollateralHeldByInsuranceCarriers
24209000 usd
CY2022Q4 tbi Collateral Commitments Cash Collateral Held By Insurance Carriers
CollateralCommitmentsCashCollateralHeldByInsuranceCarriers
23716000 usd
CY2023Q2 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
27153000 usd
CY2022Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
30857000 usd
CY2023Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
117206000 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
123678000 usd
CY2023Q2 tbi Collateral Commitments Lettersof Credit
CollateralCommitmentsLettersofCredit
6077000 usd
CY2022Q4 tbi Collateral Commitments Lettersof Credit
CollateralCommitmentsLettersofCredit
6077000 usd
CY2023Q2 tbi Collateral Commitments Surety Bonds
CollateralCommitmentsSuretyBonds
20725000 usd
CY2022Q4 tbi Collateral Commitments Surety Bonds
CollateralCommitmentsSuretyBonds
20806000 usd
CY2023Q2 tbi Collateral Commitments Total Collateral Commitments
CollateralCommitmentsTotalCollateralCommitments
195370000 usd
CY2022Q4 tbi Collateral Commitments Total Collateral Commitments
CollateralCommitmentsTotalCollateralCommitments
205134000 usd
tbi Collateral Commitments Surety Bond Annual Fee Limit Percentage Of Bond Amount
CollateralCommitmentsSuretyBondAnnualFeeLimitPercentageOfBondAmount
0.020
tbi Collateral Commitments Surety Bonds Required Cancellation Notice
CollateralCommitmentsSuretyBondsRequiredCancellationNotice
P60D
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
454045000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.065
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7323000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
24013000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11612000 usd
us-gaap Net Income Loss
NetIncomeLoss
34532000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30966000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32707000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31629000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33318000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
442000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
514000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30966000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33149000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31629000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33832000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
967000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
322000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1020000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
457000 shares
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
475588000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
569253000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
940876000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1120768000 usd
CY2023Q2 tbi Operating Profit Loss From Segments
OperatingProfitLossFromSegments
19225000 usd
CY2022Q2 tbi Operating Profit Loss From Segments
OperatingProfitLossFromSegments
45146000 usd
tbi Operating Profit Loss From Segments
OperatingProfitLossFromSegments
28818000 usd
tbi Operating Profit Loss From Segments
OperatingProfitLossFromSegments
75316000 usd
CY2023Q2 tbi Work Opportunity Tax Credit Processing Fees
WorkOpportunityTaxCreditProcessingFees
110000 usd
CY2022Q2 tbi Work Opportunity Tax Credit Processing Fees
WorkOpportunityTaxCreditProcessingFees
162000 usd
tbi Work Opportunity Tax Credit Processing Fees
WorkOpportunityTaxCreditProcessingFees
230000 usd
tbi Work Opportunity Tax Credit Processing Fees
WorkOpportunityTaxCreditProcessingFees
324000 usd
CY2023Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
952000 usd
CY2022Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
699000 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1820000 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1446000 usd
CY2023Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
9485000 usd
CY2022Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
9485000 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
174000 usd
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
1748000 usd
us-gaap Restructuring Charges
RestructuringCharges
206000 usd
us-gaap Restructuring Charges
RestructuringCharges
4298000 usd
CY2023Q2 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
565000 usd
CY2022Q2 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-491000 usd
us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
1962000 usd
us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-355000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6280000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7245000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12691000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
14532000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6556000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
29252000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-12499000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
41242000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
578000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-110000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1592000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
395000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5978000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29142000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10907000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
41637000 usd

Files In Submission

Name View Source Status
0000768899-23-000104-index-headers.html Edgar Link pending
0000768899-23-000104-index.html Edgar Link pending
0000768899-23-000104.txt Edgar Link pending
0000768899-23-000104-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbi-20230625.htm Edgar Link pending
tbi-20230625.xsd Edgar Link pending
tbi-20230625_g1.jpg Edgar Link pending
tbi062523ex1012016omnibusi.htm Edgar Link pending
tbi062523ex1022010employee.htm Edgar Link pending
tbi10q062523ex311.htm Edgar Link pending
tbi10q062523ex312.htm Edgar Link pending
tbi10q062523ex321.htm Edgar Link pending
tbi-20230625_def.xml Edgar Link unprocessable
tbi-20230625_lab.xml Edgar Link unprocessable
tbi-20230625_htm.xml Edgar Link completed
tbi-20230625_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
tbi-20230625_pre.xml Edgar Link unprocessable